"Once having an mAb/hybridoma cell line of interest, it is crucial to obtain the sequence information for a variety of reasons:
● To secure your IP: sequence information especially the V region sequence is of great value for dictating the uniqueness of your antibody candidates, which takes a key part in patent application to secure your exclusive rights.
● To enable recombinant expression: accurate sequence info can guarantee continuous antibody production in various recombinant systems, in case of problems like gene loss, drift, mutation, hybridoma contamination, etc.
● To facilitate downstream development: antibody sequence can serve as blueprint for subsequent optimization & engineering work such as humanization, affinity maturation, etc., which are essential steps for broadening therapeutic potentials.
Due to the high specificity and affinity against particular targets, antibody molecules have long been significantly used as biochemical tools for selection, identification and purification. IgClue has established a comprehensive portfolio of research-ready antibody products for various experimental applications, such as western blot, flow cytometry, ELISA, and IHC etc. With multiple host species, extensive target catalogs and application areas, we offer following antibody products to best benefit your research endeavors. http://www.igclue.com/research-antibody-products.html
Fully understanding the critical needs, IgClue has developed a full product line of therapeutic antibodies backed by our well-established antibody manufacture platform and scientific expertise. Our catalog now covers almost all marketed antibody drugs available for diverse indications, such as cancer, infectious disease, inflammatory conditions, etc. Quality antibodies can be guaranteed with zero endotoxin, fully verified functionalities that are ready to be used in various in vitro/in vivo assays. http://www.igclue.com/therapeutic-antibody-products.html
"In additional to conventional research / therapeutic antibody products, IgClue is also specialized in tailoring various other types of antibody products to suit your specific needs:
Chicken IgY
Agonistic & antagonistic antibodies
Single Domain Antibodies
http://www.igclue.com/other-antibody-products.html"
If you cannot find an expected product or look forward to a specific solution to your research questions, our customized services are the best option to cater your needs. In addition, the comprehensive product categories, Ig Clue is also specialized in tailoring various service programs to suit custom needs. Based on our advanced technical platform and experienced staff scientists, we are always dedicated in providing professional antibody-related services to facilitate your lab research progress on a budget and timeframe that exceed expectations. http://www.igclue.com/customized-solutions.html
Specialized in antibody development & production, IgClue currently provides professional antibody labeling service to meet your demands. In our lab it is feasible to adopt diverse bioactive tags to your antibody of interest. Our skillful scientists will select the best strategy (or strategies) to generate ideal products for your downstream applications. http://www.igclue.com/antibody-labeling.html
In addition to a full range of ready-made antibody products, IgClue is also professional in generating custom monoclonal & polyclonal antibodies to fit your specific purpose. Based on our leading technique platform as well as highly skilled scientists, we can rapidly evaluate, identify an optimal production scheme for your candidate antibody, and deliver the final products in a highly efficient and reliable way. http://www.igclue.com/custom-antibody-production.html
"If the target happens not to be included in our catalog, it is time to develop a custom project. Equipped with multiple leading technologies as well as highly skilled scientific team in IgClue, we are always happy to tailor customized antibody development projects to support our clients’ research endeavors.
Two well-established strategies are used for antibody generation against a give antigen:
● Custom Antibody Development via Hybridomas
● Custom Antibody Development via Phage Display
"In aim of overcoming this challenge, IgClue has introduced an innovative EpiLink™ technical platform. It is based on chemical cross-linking of proteins coupled with mass spectrometry analysis (CXMS) technique, which can outline the overall protein architecture via identifying direct binding partners and localizing the binding interface. Yet, conventional CXMS may have problems detecting and analyzing interlinked peptides, the most informative category that faithfully reflects antigen-antibody interaction. Therefore, EpiLink™ is peculiarly designed with to identify and interpret specific cross-linking spectra with enhanced sensitivity and accuracy, in a simple and efficient way.
Highlights of EpiLink™ antibody epitope mapping platform:
● Designed specifically to identify and interpret cross-linking spectra, allowing for higher sensitivity and accuracy
● Able to detect conformational epitopes in original folding at amino acid level.
● Only very small sample size is required
● Fast and efficient, with a very short lead-time.
● Highly skilled team with rich experience from a number of previous successful cases in utilizing EpiLink™ antibody epitope mapping
Primary antibodies represent a powerful tool in many laboratory techniques to fulfil basic research tasks. Primary antibodies acting as key links to detect, analyze and manipulate certain substances. Nowadays, they are extensively used in flow cytometry, immunoprecipitation, Western blotting, ELISA, ELISPOT and many other experiments. Specialized in antibody development and manufacture, IgClue has tailored a full range of primary antibody products, covering most research targets of interest. We offer following products to facilitate your research success.
"IgClue proudly presents our high-quality monoclonal antibody products to our customers. With multiple host species, flexible modifications and various application areas, our monoclonal primary antibodies can be an ideal tool to facilitate your experiment.
Monoclonal antibodies are highly selective immunoglobulin that only interact with one antigen epitope. Since the invention of hybridomas in 1975, monoclonal antibodies have been extensively used in a broad range of laboratory techniques to answer basic research questions, such as:
Identify and locate intracellular and extracellular components
Investigate protein expression
Track proteins within cells & tissues
Protein separation (e.g. immunoprecipitation / co-immunoprecipitation)"
"Polyclonal antibodies serve as excellent primary antibodies in many laboratory techniques. One most important feature of polyclonal antibody is their high titer and affinity. With higher sensitivity and ability to recognize more than one site of a given antigen, polyclonal antibodies can be very superior in amplifying signals from target, getting better results in IP/ChIP. Polyclonal antibodies tolerating antigen conformational changes as well as detecting de-natured proteins. In comparison with monoclonal antibodies, polyclonal antibodies are relatively cheaper and less time-consuming which makes them a very good research tool. However, if you are looking for high selectivity or only interested in a specific antigen domain or epitope, monoclonal antibodies could be a more suitable option.
IgClue now integrates a full portfolio of polyclonal antibody products to optimize your scientific experience. We offer reliable, research-ready polyclonal antibodies (chicken, goat, rabbit, mouse, etc.) against a variety of targets.
We also provide customized solutions if you have any specific requests. Please don’t hesitate to contact us for more information."
"Epitope tags are frequently used in recombinant protein expression. IgClue now provides a wide selection of primary antibodies specific to epitope tags to benefit your research progress. By introducing a unique sequence of amino acids at N-/C-terminal of a recombinant protein. The final products can be directly detected via corresponding epitope tag antibodies, which greatly simplifies the process of protein identification and separation, etc.
Dedicated in antibody research & development for years, IgClue now offers fully-validated primary antibody products against most of the commonly used epitope tags, fluorescent dyes as well as fusion proteins, including but not limited to:
His (6-Histidine)
cMyc
HA (Hemagglutinin)
FLAG
GST
HRP
DyLight dyes
And more...
In addition to antibodies against epitope tags, we also have antibody labeling service to conjugate your antibody to specific tags or dyes. Our scientists invite you to contact us and discuss how IgClue can help on your ongoing research."
Due to the high specificity and affinity against particular targets, antibody molecules have long been significantly used as biochemical tools for selection, identification and purification. IgClue has established a comprehensive portfolio of research-ready antibody products for various experimental applications, such as western blot, flow cytometry, ELISA, and IHC etc. With multiple host species, extensive target catalogs and application areas, we offer following antibody products to best benefit your research endeavors. http://www.igclue.com/research-antibody-products.html
Fully understanding the critical needs, IgClue has developed a full product line of therapeutic antibodies backed by our well-established antibody manufacture platform and scientific expertise. Our catalog now covers almost all marketed antibody drugs available for diverse indications, such as cancer, infectious disease, inflammatory conditions, etc. Quality antibodies can be guaranteed with zero endotoxin, fully verified functionalities that are ready to be used in various in vitro/in vivo assays. http://www.igclue.com/therapeutic-antibody-products.html
Fully understanding the critical needs, IgClue has developed a full product line of therapeutic antibodies backed by our well-established antibody manufacture platform and scientific expertise. Our catalog now covers almost all marketed antibody drugs available for diverse indications, such as cancer, infectious disease, inflammatory conditions, etc. Quality antibodies can be guaranteed with zero endotoxin, fully verified functionalities that are ready to be used in various in vitro/in vivo assays. http://www.igclue.com/therapeutic-antibody-products.html
Specialized in antibody development & production, IgClue currently provides professional antibody labeling service to meet your demands. In our lab it is feasible to adopt diverse bioactive tags to your antibody of interest. Our skillful scientists will select the best strategy (or strategies) to generate ideal products for your downstream applications. http://www.igclue.com/antibody-labeling.html
Specialized in antibody development & production, IgClue currently provides professional antibody labeling service to meet your demands. In our lab it is feasible to adopt diverse bioactive tags to your antibody of interest. Our skillful scientists will select the best strategy (or strategies) to generate ideal products for your downstream applications. http://www.igclue.com/antibody-labeling.html
In addition to a full range of ready-made antibody products, IgClue is also professional in generating custom monoclonal & polyclonal antibodies to fit your specific purpose. Based on our leading technique platform as well as highly skilled scientists, we can rapidly evaluate, identify an optimal production scheme for your candidate antibody, and deliver the final products in a highly efficient and reliable way. http://www.igclue.com/custom-antibody-production.html
In addition to a full range of ready-made antibody products, IgClue is also professional in generating custom monoclonal & polyclonal antibodies to fit your specific purpose. Based on our leading technique platform as well as highly skilled scientists, we can rapidly evaluate, identify an optimal production scheme for your candidate antibody, and deliver the final products in a highly efficient and reliable way. http://www.igclue.com/custom-antibody-production.html
"Once having an mAb/hybridoma cell line of interest, it is crucial to obtain the sequence information for a variety of reasons:
● To secure your IP: sequence information especially the V region sequence is of great value for dictating the uniqueness of your antibody candidates, which takes a key part in patent application to secure your exclusive rights.
● To enable recombinant expression: accurate sequence info can guarantee continuous antibody production in various recombinant systems, in case of problems like gene loss, drift, mutation, hybridoma contamination, etc.
● To facilitate downstream development: antibody sequence can serve as blueprint for subsequent optimization & engineering work such as humanization, affinity maturation, etc., which are essential steps for broadening therapeutic potentials.
"Once having an mAb/hybridoma cell line of interest, it is crucial to obtain the sequence information for a variety of reasons:
● To secure your IP: sequence information especially the V region sequence is of great value for dictating the uniqueness of your antibody candidates, which takes a key part in patent application to secure your exclusive rights.
● To enable recombinant expression: accurate sequence info can guarantee continuous antibody production in various recombinant systems, in case of problems like gene loss, drift, mutation, hybridoma contamination, etc.
● To facilitate downstream development: antibody sequence can serve as blueprint for subsequent optimization & engineering work such as humanization, affinity maturation, etc., which are essential steps for broadening therapeutic potentials.
"Once having an mAb/hybridoma cell line of interest, it is crucial to obtain the sequence information for a variety of reasons:
● To secure your IP: sequence information especially the V region sequence is of great value for dictating the uniqueness of your antibody candidates, which takes a key part in patent application to secure your exclusive rights.
● To enable recombinant expression: accurate sequence info can guarantee continuous antibody production in various recombinant systems, in case of problems like gene loss, drift, mutation, hybridoma contamination, etc.
● To facilitate downstream development: antibody sequence can serve as blueprint for subsequent optimization & engineering work such as humanization, affinity maturation, etc., which are essential steps for broadening therapeutic potentials.
"Once having an mAb/hybridoma cell line of interest, it is crucial to obtain the sequence information for a variety of reasons:
● To secure your IP: sequence information especially the V region sequence is of great value for dictating the uniqueness of your antibody candidates, which takes a key part in patent application to secure your exclusive rights.
● To enable recombinant expression: accurate sequence info can guarantee continuous antibody production in various recombinant systems, in case of problems like gene loss, drift, mutation, hybridoma contamination, etc.
● To facilitate downstream development: antibody sequence can serve as blueprint for subsequent optimization & engineering work such as humanization, affinity maturation, etc., which are essential steps for broadening therapeutic potentials.
"Once having an mAb/hybridoma cell line of interest, it is crucial to obtain the sequence information for a variety of reasons:
● To secure your IP: sequence information especially the V region sequence is of great value for dictating the uniqueness of your antibody candidates, which takes a key part in patent application to secure your exclusive rights.
● To enable recombinant expression: accurate sequence info can guarantee continuous antibody production in various recombinant systems, in case of problems like gene loss, drift, mutation, hybridoma contamination, etc.
● To facilitate downstream development: antibody sequence can serve as blueprint for subsequent optimization & engineering work such as humanization, affinity maturation, etc., which are essential steps for broadening therapeutic potentials.
